Options recommendationBuy Nifty 21700pe in the range Rs. 74-77 Target: Rs. 105 Stoploss: Rs. 59

Posted on by Raj Gaurav Rai
Options recommendationBuy Nifty 21700pe in the range Rs. 74-77 Target: Rs. 105 Stoploss: Rs. 59
Options recommendationBuy Nifty 21700pe in the range Rs. 74-77 Target: Rs. 105 Stoploss: Rs. 59

Options recommendation

Buy Nifty 21700pe in the range Rs. 74-77
Target: Rs. 105
Stoploss: Rs. 59

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

Global Indices GIFT Nifty: 22032 +85 Hangseng: 18549 +105 Dow: 38711 +140 S&P 500: 5291.34 +8 Nasdaq: 16853.74 +25 USD / INR: 83.57 Brent Crude: 77.53 GOLD: 2349.40 FII Net (04-06-2024): -12436.22 DII Net (04-06-2024): -3318.98 Global Indices GIFT Nifty: 22032 +85 Hangseng: 18549 +105 Dow: 38711 +140 S&P 500: 5291.34 +8 Nasdaq: 16853.74 +25 USD / INR: 83.57 Brent Crude: 77.53 GOLD: 2349.40 FII Net (04-06-2024): -12436.22 DII Net (04-06-2024): -3318.98

Global Indices GIFT Nifty: 22032 +85Hangseng: 18549 +105Dow: 38711 +140S&P 500: 5291.34 +8Nasdaq: 16853.74 +25USD / INR: 83.57Brent Crude: 77.53GOLD: 2349.40FII Net (04-06-2024): -12436.22DII Net […]

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory […]